SCHEMBL2834140

SCHEMBL2834140

O=S(=O)(O)c1c(/C=C/c2cccc(N=C=S)c2S(=O)(=O)O)cccc1N=C=S

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD1 O60671 1/20 0.48
P2RY6 Q15077 1/20 0.48
ALDH1A1 P00352 4/20 0.40
POLB P06746 1/20 0.40
CYP3A4 P08684 3/20 0.39
HPGD P15428 3/20 0.39
HSD17B10 Q99714 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
ABCB11 O95342 1/20 0.39
NR3C1 P04150 1/20 0.39
CYP1A2 P05177 1/20 0.39
ADRA2A P08913 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
ALOX15 P16050 1/20 0.39
ADRA2C P18825 1/20 0.39
MAOA P21397 1/20 0.39
DRD1 P21728 1/20 0.39
SLC6A4 P31645 1/20 0.39
HTR2B P41595 1/20 0.39
CCR2 P41597 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL156112 0.98 RAD1 (0.47) RAD1P2RY6ALDH1A1POLBCYP3A4
SCHEMBL29978315 0.92 RAD1 (0.51) RAD1P2RY6ALDH1A1POLBCYP3A4
SCHEMBL344713 0.92 RAD1 (0.51) RAD1P2RY6ALDH1A1POLBCYP3A4
SCHEMBL5364759 0.92 RAD1 (0.51) RAD1P2RY6ALDH1A1POLBCYP3A4
SCHEMBL6114392 0.81 ALDH1A1 (0.50) RAD1P2RY6ALDH1A1POLBCYP3A4
SCHEMBL2834143 0.77 RAD1 (0.51) RAD1P2RY6ALDH1A1POLBCYP3A4
SCHEMBL29225411 0.76 P2RY6 (0.53) RAD1P2RY6ALDH1A1CYP3A4HPGD
SCHEMBL156114 0.76 RAD1 (0.50) RAD1P2RY6ALDH1A1POLBCYP3A4
SCHEMBL9358944 0.74 RAD1 (0.55) RAD1P2RY6ALDH1A1POLBCYP3A4
SCHEMBL9358952 0.73 RAD1 (0.41) RAD1P2RY6ALDH1A1CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111971048-A Combination therapy for the treatment of cancer 杰克逊实验室 2020-11-20 CN claimed
US-20200123595-A1 Method for Detecting Bacteria GFC DIAGNOSTICS LTD (GB) 2020-04-23 US claimed
US-7211414-B2 Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity VISIGEN BIOTECHNOLOGIES, INC. (US) 2007-05-01 US claimed
EP-1082006-A1 CRYOPRESERVATION OF HUMAN RED BLOOD CELLS LIFECELL CORPORATION (US) 2001-03-14 EP claimed
WO-1999060849-A1 CRYOPRESERVATION OF HUMAN RED BLOOD CELLS LIFECELL CORPORATION (US) 1999-12-02 WO claimed
WO-2025106804-A1 COMPOSITIONS AND METHODS FOR CHARACTERIZING HEPATOCYTE STRESS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-05-22 WO disclosed
US-20250136972-A1 MODIFIED FLOW PROXY ASSAY PRIOR TO SINGLE-CELL CITE-SEQ BECTON, DICKINSON AND COMPANY 2025-05-01 US disclosed
US-20250066761-A1 REFERENCE BEADS FOR LINKING IMAGING AND SEQUENCING READOUTS WITH SINGLE-CELL RESOLUTION BECTON, DICKINSON AND COMPANY 2025-02-27 US disclosed
EP-4399327-A1 NON-SEQUENCING PCR-BASED METHOD FOR DETECTION OF ANTIBODY-CONJUGATED OLIGONUCLEOTIDES Becton, Dickinson and Company (US) 2024-07-17 EP disclosed
EP-4396581-A1 MULTIPLEXED PROTEOMICS ANALYSIS USING OLIGONUCLEOTIDE-CONJUGATED ANTIBODIES Becton, Dickinson and Company (US) 2024-07-10 EP disclosed
EP-4329762-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF Cornell University (US) 2024-03-06 EP disclosed
WO-2023239730-A1 SYSTEMS FOR RECONSTITUTING DRIED REAGENT COMPOSITIONS AND METHODS FOR USING THE SAME BECTON, DICKINSON AND COMPANY (US) 2023-12-14 WO disclosed
WO-2000036151-A9 A HETEROGENEOUS ASSAY FOR PYROPHOSPHATE DETECTION LI COR INC (US) 2001-08-02 WO disclosed
EP-1082006-A1 CRYOPRESERVATION OF HUMAN RED BLOOD CELLS LIFECELL CORPORATION (US) 2001-03-14 EP disclosed
WO-2000036151-A1 A HETEROGENEOUS ASSAY FOR PYROPHOSPHATE DETECTION LI-COR, INC. (US) 2000-06-22 WO disclosed
WO-1999060849-A1 CRYOPRESERVATION OF HUMAN RED BLOOD CELLS LIFECELL CORPORATION (US) 1999-12-02 WO disclosed
EP-0938585-A1 DETECTION AND QUANTITATION OF ENDOTOXIN BY FLUORESCENCE POLARIZATION ASSOCIATES OF CAPE COD, INC. (US) 1999-09-01 EP disclosed
WO-1998021357-A1 DETECTION AND QUANTITATION OF ENDOTOXIN BY FLUORESCENCE POLARIZATION ASSOCIATES OF CAPE COD, INC. (US) 1998-05-22 WO disclosed
EP-0626945-A1 SULFONIC ACID DERIVATIVES IN THE TREATMENT OF VIRAL DISEASES MERRELL PHARMACEUTICALS INC. (US) 1994-12-07 EP disclosed
WO-1993016992-A1 SULFONIC ACID DERIVATIVES IN THE TREATMENT OF VIRAL DISEASES MERRELL DOW PHARMACEUTICALS INC. (US) 1993-09-02 WO disclosed